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West Nile Virus (WNV) collected from 179 human blood donors in 25 US states and three Canadian provinces during the 2003 and 2004
epidemic seasons were genetically analyzed. The evolution of WNV during its Western spread was examined by envelope (E) gene sequencing of
all 179 cases and full open reading frame sequencing of a subset of 20 WNV to determine if geographic and temporal segregation of distinct viral
variants had occurred. Median joining network analysis was used to examine the genetic relationship between E gene variants and identified four
large genetic clusters showing the gradual accumulation of mutations during the virus' western expansion. Two related WNV variants and their
descendents, undetected in prior years, expanded in frequency. Apparent founder effects were observed in some regional outbreaks possibly due to
local WNV colonization by a limited number of viruses. Amino acid mutations associated with newly expanding genetic variants reflect either
selectively neutral mutational drift and/or mutations providing replicative advantages over the previously dominant forms of WNV.
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In 1999, West Nile Virus (WNV) (Flaviviridae, Flavivirus)
was introduced in the western hemisphere causing an outbreak
characterized by an equine and avian epizootic and 62 cases of
humans encephalitis in New York City resulting in seven deaths
(Murgue et al., 2002; Nash et al., 2001). Full genome sequences
of early North American WNV variants demonstrated the close
genetic relationship between US WNV variants and those
obtained in 1998 and 1999 from Israel (Jia et al., 1999; Lanciotti⁎ Corresponding author. Blood Systems Research Institute, 270 Masonic Ave,
San Francisco, CA 94118, USA. Fax: +1 415 2762311.
E-mail address: delwarte@medicine.ucsf.edu (E. Delwart).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.01.019et al., 1999). Since then,WNVdistribution has expanded tomost
parts of North America including all contiguous US states,
Canada, the Caribbean islands andMexico (Blitvich et al., 2003;
Estrada-Franco et al., 2003; Komar et al., 2005; Lefrancois et al.,
2005). WNV has also been a significant public health issue since
1999 as thousands have been symptomatically infected (http://
www.cdc.gov/ncidod/dvbid/westnile/).
RNA viruses are notable for their high mutations rates and
therefore their potential for rapid evolution (Holland et al.,
1982) although for WNV the need to replicate in both insects
and birds may impose special constraints on their genomic
plasticity. Focusing largely on sequencing of the pre-membrane
(prM) and the envelope (E) genes, as well as full open reading
frames (ORF), prior analyses have revealed mutations relative
Table 1
Geographical distribution of plasma samples
State City Year
2003 2004
Arizona Tempe 10
Arkansas Little Rock 1
California San Francisco 1
Los Angeles 3
La Habra 1
San Diego 1
Ontario 1
Colorado Penrose 2
Grand Junction 8
Florida Miami 2 1
Orlando 1
Tampa 9
Gainsville 3
Illinois Glenview 2
Indiana Indianapolis 3
South Bend 3
Iowa Davenport 1
Sioux City 2
Louisiana New Orleans 6
Shreveport 2
Minnesota Minneapolis 3
Rochester 1
Sanborn 1
Missouri Kansas City 3
Nebraska Lincoln 3
Nevada Las Vegas 2
New Mexico Albuquerque 3 8
New York New York 3
North Dakota Bismark 12
Ohio Elyria 1
Oklahoma Oklahoma City 8
Pennsylvania Bethlehem 1
South Carolina Goose Creek 1
South Dakota Rapid City 13 1
Sioux Falls 3
Tennessee Memphis 1
Jackson 2
Texas Lubbock 4
Amarillo 7
Dallas 2
San Antonio 5
El Paso 4
Houston 1
Tyler 5
Wisconsin Milwaukee 4
Wyoming Cheyenne 2
Canada
Alberta 3
Manitoba 1
Sasketechuan 8
Total 137 42
221B.L. Herring et al. / Virology 363 (2007) 220–228to the prototype 1999 North American WNV virus during the
expansion of the virus across North America (NY99, GenBank
Accession no. AF196835). In some cases viral mutations could
be grouped temporally or geographically (Beasley et al., 2003;
Davis et al., 2003, 2005; Ebel et al., 2004; Lanciotti et al.,
2002). These studies have highlighted the emergence of a new
dominant variant lineage, named the North American 2002–
2004 clade, increasingly prevalent in numerous North American
areas in recent years (Davis et al., 2005; Ebel et al., 2004).
Because of the transient viremia in humans which resolves
prior to the onset of symptoms, very few WNV variant se-
quences have been derived from infected humans and most
WNV have been derived from infected mosquito pools, directly
or after culture in Vero cells, as well as various avian species and
horses. Large-scale investigation of the WNV actually trans-
mitted to humans has therefore not been previously possible. In
2006 less than 15 WNV sequences available in Genbank were
labeled as derived from humans.
In 2002 it was determined that WNV could be transmitted
through blood transfusions (CDC, 2002; Harrington et al.,
2003; Hollinger and Kleinman, 2003; Pealer et al., 2003). As a
consequence screening of the blood supply for WNV RNAwas
initiated in 2003, removing a significant number of potentially
infectious donations (Busch et al., 2005, 2006; Kleinman et al.,
2005; Stramer et al., 2005; Montgomery et al., 2006). We report
here on the E gene and full ORF sequences of WNV variants
from voluntary blood donors collected across the US and
Canada in 2003 and 2004.
Results
Amplification of WNV samples and sequence analysis
The E gene was amplified by nested PCR from 179 plasma
samples from WNV RNA positive blood donors and directly
sequenced (see Materials and methods). Plasma samples were
obtained from 46 blood centers in 25 US states and 3 Canadian
provinces during the 2003 and 2004 WNV epidemic seasons
(Busch et al., 2006; Montgomery et al., 2006; Stramer et al.,
2005) (Table 1). Nucleotide sequences of the E gene were
compared to the prototype strain from 1999 NY (AF196835).
Overall, nucleotide differences were observed at a total of 52
positions (3.6%) and the majority of changes (n=45) were
synonymous. Only two out of 179 WNV sequences were
identical to NY99, both collected in 2003 in central Florida. An
amino acid change at E-V159A resulting from a U>C mutation
at position 1442 was observed in all but 3 (all from Central
Florida) of our 179 WNV sequences collected in 2003 and
2004. While the large majority of mutations were sporadic
(observed in only one virus) others were more common
necessitating the use of network analysis to facilitate visualiza-
tion of the relationships between these closely related variants.
Ambiguous or mixed bases were also observed at numerous
positions following direct sequencing of the WNV RT-PCR
products, indicating the presence of genetically mixed viral
quasi-species in these recently infected, pre-seroconversion,
blood donors. Such viral quasi-species diversity may have veryrapidly evolved following a clonal human infection or result from
inoculations with multiple WNV variants from insect bite(s)
(Jerzak et al., 2005).
Network analysis of E gene variants
Median joining network analysis was used here to facilitate
visualization of the genetic relationship between the WNV
222 B.L. Herring et al. / Virology 363 (2007) 220–228(Bandelt et al., 1999). Network analysis was performed using
sequences from this study and other US and Canadian
derived WNV sequences available in Genbank at the time ofFig. 1. Genetic network analysis of E gene region of North AmericanWNV. (a) Label
linking nodes X, A, B, C, and D is included. (b) Labeled by time zone. Network pos
corresponds to colored circle closest to variant name. Nodes labeled A–D, X, and Ya
Multiple lines converging on a single peripheral variant indicate alternative mutatioanalysis. Networks are labeled by years of sample collection
(1999–2004) (Fig. 1a) and by geographic origin (eastern,
central, mountain, and pacific states time zones) (Fig. 1b).ed by year of collection from 1998 (Israel) to 2004. Location of E gene mutations
ition of blood donors WNV variants whose full genomes are analyzed in Fig. 2
re defined in text. White circles correspond to hypothetical intermediate variants.
nal pathways.
Table 2
Primers used for the amplification and sequencing of the WNV genome
NY99 pos.
nPCR primers
F1 + CTGACAAACTTAGTAGTGTTTGTGAGG 20–46
nF1a + TGCGAGCTGTTTCTTAGCAC 67–86
F2 + CACCTTTGTGGTTGATGGTC 2862–2881
nF2a + TCGCGCTTGGAATAGCTTAG 2910–2929
nR1a − CCTTTCAAGCTTCCACGTATC 3091–3111
R1 − GCCCTGGTTTTGTGTCTTG 3249–3267
F3 + ATTGCCCTTTGCCTACAACG 5725–5744
nF3a + GCCTACAACGTGCTGGAAAG 5735–5754
nR2a − GGCATGTTGATGTTGTCCAG 6097–6116
R2 − TCTCTCTTCTCCTCTGAGCCG 6184–6204
F4a + TGGTGTTACTATATGGAACC 7939–7959
nF4aa + GGAACATTGTCACCATGAAGAG 8042–8063
nR3a − TGCCACGTCGAACTGTACTC 8545–8564
R3 − TGAGAGGAGCCTGACCACTC 8654–8673
nR4aa − TGAGGGCTTACATGGATCAC 10,597–10,616
R4a − TATCGCAGACTGCACTCTCC 10,696–10,715
Sequencing
F2b + TGTCGTGCTATTGCTTTTGG 930–949
S1 + CTCCACACAGGTTGGAGCCACTCAGGCAGG 1431–1460
R2b − TCTATGGCACACCCAGTGTC 2470–2489
SEG1 + ACTTACACTGATGTGTTACG 3673–3692
SEG2 + AGTGATGCAGAAATTACAGG 4408–4427
SEG3 + GATGGATGAGCCAATCCCAG 5121–5140
SEG4 + GAAAGATGCCTGAGCACTTC 6497–6516
SEG5 + AAGTCACCCTCACCGTTACG 7229–7248
SEG6 + GCGAGTGTTCAAAGAGAAGG 8742–8761
SEG7 + GTGGACAAGTTGTCACCTAC 9491–9510
SEG8 + GAGGACATCTGGTGTGGCAG 10,222–10,241
a PCR primers also used for sequencing. +, sense primers; − antisense primers.
223B.L. Herring et al. / Virology 363 (2007) 220–228The length of network connections reflects the number of
mutations.
The 1998 sequence from Israel (Fig. 1a in red) is the pre-
existing WNV variant most closely related to those of the 1999
N. American outbreak. In the E gene region analyzed, one to two
mutations separated IS-98 from all US variants collected in 1999
(Fig. 1a in green). All 1999 US variants fell within node A or
directly radiated from it (Fig. 1a in green). Also connected to
node A and carrying the ancestral North American nucleotide U
at position 1442 were all the variants collected in 1999 and 2000
and the large majority of 2001 WNV. The 26 WNV variants
within node Awere exclusively from the Eastern US states with a
single exception from Louisiana (Fig. 1b). All variants radiating
from node Awere also exclusively from Eastern US states except
for a genetically homogenous but highly divergent group of 8
WNV variants detected in 2002 from birds and insects in
Southern Texas (Davis et al., 2003) (Fig. 1b node Y). No member
nor descendent of this divergent group of Southern Texas WNV
variants have since been reported (Davis et al., 2005).
One or more node A variant(s) carrying the non-synonymous
U1442Cmutation (resulting in E-V159A) founded E gene node B
which contains the largest number of WNV in this analysis and
corresponds to theNorthAmerican, 2002–2004 cluster defined by
Davis et al. (2005) (Figs. 1a and b node B). The majority ofWNV
in blood donors in central US states and the majority of 2003
variants overall belonged to node B and its radiating variants.
One or more node B variant(s) carrying a synonymous
A1320G mutation then founded node C consisting of 10 WNV
from the central and mountain states collected in 2003 and
2004 (Figs. 1a and b).
One or more node C variant(s) carrying a synonymous
C1974U mutation then gave rise to the D node (Figs. 1a and b).
The majority of node D and radiating variants in viremic donors
were collected in the mountain states in 2004, mainly from
Arizona.
Using network analysis, a stepwise accumulation of mu-
tations in the E gene loci was therefore associated with the
westward progression of WNV (node A>U1442C>node
B>A1320G>node C>C1974U>node D). Interestingly the
synonymous C1974U mutation was also seen linking node A to
the small X node (Figs. 1a and b node X) consisting of 6 WNV
and 11 radiating variants all collected in NY state in 2000 to
2003 (Fig. 1a). The synonymous C1974U mutations therefore
appeared in two genetic backgrounds possibly reflecting its
independent emergence on at least two occasions.
The geographic distribution of variants did not appear random
as in some cases clusters of closely related variants were
collected during the same season by the same blood banks. Such
unevenWNV variant distribution indicated that some of the local
WNV outbreaks may have been initiated by only a few or by
multiple, but genetically closely related, founder viruses. Nine
out of ten of the 2004 WNV from Tempe AZ were members of
node D and one radiated from node D. Clusters of WNV variants
carrying the same E gene signature mutations seen in no other
WNV were also detected in the following areas. Four out of five
2004 WNV from the Los Angeles area contained a unique
mutation at position 2257. Three out of eight variants collected inGrand Junction, CO in 2004 contained a four-mutation genetic
signature (1065, 1089, 1620, 2070). Three out of five 2003
variants from San Antonio, TX contained a distinct mutation at
position 2278 while the other two San Antonio variants both
contained a three-mutations signature (1221, 1239, 1995). Three
out of eight variants from 2003 Oklahoma City had distinct
mutations at positions 1134, 1983, and 1995. Both variants from
2004 Shreveport, LA had the same 2304 mutation. A large
fraction of WNV in each of the above blood collection centers
therefore contained viruses that were genetically related and
distinguishable from those in other areas during the same year.
Amplification and sequencing of the nearly complete WNV
open reading frame
In order to confirm and extend the results of the E gene
analysis and to further examine the possibility of founder effects
in local outbreaks, we selected 20 samples from different geo-
graphical areas for full genome sequencing (Grand Junction, CO
2004 (n=4), Tampa, FL 2003 (n=3), Amarillo, TX 2003 (n=2),
Los Angeles, CA 2004 (n=2), Tempe, AZ 2004 (n=2),
Albuquerque, NM (n=2), San Francisco, CA 2004 (n=1), San
Diego, CA 2004 (n=1), Rapid City, SD 2004 (n=1), Glenview,
IL 2003 (n=1), Milwaukee, WI 2003 (n=1)). RT-PCR and
sequencingwere performed directly from human plasma (Table 2
and see Materials and methods).
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Genbank AF196835), we detected mutations in 275 positions
out of the 10508 nucleotide sequenced. An average of 0.29% of
the nucleotides differed between the 2003–2004 sequences and
the NY99 reference strain (range of 0.2–0.35%). Relative to the
Eastern US clade consensus sequence nine synonymous mu-
tations were identified in most of the newly sequenced 2003–
2004 genomes (C660U (C), C2466U (E), A4146G (NS2A),
C4803U (NS3), C6138U (NS3), C6238U, C6426U (NS3),
C6996U (NS4B), U7938C (NS5) and C9352U (NS5)). Except
for C660U, present in only 15/20 of sequenced genomes and
C6238U present in only 11/20 genomes, these nine synon-
ymous mutations were found in 19/20 of the 2003–2004
sequenced genomes and were therefore associated with the
replacement of the early (1999–2003) Eastern US clade by the
North American 2003–2004 clade and its derived sub-clusters
including nodes C and D. One WNV (Fig. 2 03-113 Tampa FL),
phylogenetically basal to the North American 2003–2004 clade,
carried only 4/9 of these mutations (A4146G, C6138U,
C6426U, and U7938C) presumably representing an intermedi-Fig. 2. Phylogenetic analysis of WNV genomes. Blood donors WNVare shown in thic
(Israel 1998), and selected variants from Davis et al. (2005) are in italic font. Variant
located left of the vertical bars.ate form. A phylogenetic analysis of the complete genomes was
performed including representative genomes sampled by Davis
et al. (2005) (Fig. 2). The 03-113 Tampa FL ORF, whose E gene
fell within node B, clustered with 2 other database sequences
(Fig. 2 OH 2002 and Mexico, Tabasco) and was phylogeneti-
cally located betwen the two major genome clades, the Eastern
US and the North American 2002-2004 clades (Davis et al.,
2005).
The overall topology of that tree reflected the lines of descent
seen in the E gene network analysis. The 2004 NM variants (04-
236NM and 04-327NM) branched off the same lineage that led
to the 2004 AZ and CO variants (04-251AZ, 04-252AZ, 04-
216CO, 04-219CO) just as these NM variants radiated from
node C and the AZ and CO variants radiated from node D (Figs.
1b and 2). The four node D variants were closely related at the
genome level with another Arizona 2004 genome sequence
derived by Davis et al. (2005) (AZ 2004-DQ164201). The other
two 2004 CO variants (04-214CO, 04-218CO) branched off
together from the major group of sequences corresponding to
the North American 2002–2004 cluster much as they radiatedk font while the reference USWNV variant (NY 1999), 1998 variant from Israel
s belonging to genetic network defined nodes or previously defined clusters are
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genome phylogenetic analysis also uncovered relationships not
detected using only E gene sequence. Of the four 2004 CA
variants genome sequenced, only the two from the Los Angeles
area clustered using E gene alone in the network analysis (04-
240CA, 04-244CA) while the other two variants (04-213CA,
04-238CA) from the San Francisco and San Diego area fell into
node B (Fig. 1b). Using full genome sequences these four
viruses clustered together with bootstrap values of 100/100
together with another avian variant reported by Davis et al.
(2005) (CO 2003 1-DQ164204) reflecting an apparent common
ancestry for all four sampled Californian WNV that was not
detected using E gene alone (Fig. 2). A 2003 variant from TX
(03-022TX) and another from 2004 in SD (04-233SD) both in
node B by E gene network analysis (Fig. 1b) showed a close
relationship by whole genome analysis (100/100 bootstrap)
(Fig. 2). The other 5 WNV genomes sequences were part of the
major North American 2002–2004 cluster (Davis et al., 2005)
but did not specifically cluster with other database variants (Fig.
2). In the network analysis, these 5 variants belonged to or
radiated from node B (Fig. 1b). Full genome sequencing
therefore confirmed, with increased confidence, clustering
detected using E gene alone in the network analysis and in
some cases revealed previously undetected relationships.
Amino acid signatures were also seen in the genome-based
clusters. The Mountain state cluster consisting of two Albu-
querque, NM variants plus two Tempe, AZ and two Grand
Junctions, CO variants (Fig. 2) (radiating from node C and D in
E gene respectively) (Fig. 1b), all carried the non-synonymous
mutations NS4A A85T and NS5 K314R. The other two Grand
junctions CO variants clustering separately (radiating from node
B in env) carried the unique NS5, R422K mutation. The four
Pacific cluster genomes from California (Fig. 2) were cha-
racterized by E V431I, NS4A F92L, and NS4A V135M non-
synonymous mutations.
Discussion
We report here on a genetic analysis of WNV from various
North American locations during the 2003 and 2004 epidemic
seasons and compare them to pre-existingWNV variants mostly
derived from mosquitoes and bird surveillance. This study
included 179 infected human blood donors and used direct
amplification and sequencing of WNV from plasma without
prior tissue culture viral amplifications. Both E gene and nearly
complete genome sequences were generated to analyze the
evolution of this epidemic, focusing on WNV variants that
reached their human hosts as a result of insect bites.
Our sampling revealed the presence of 3 main clusters of
WNV circulating in the continental US and Western Canadian
provinces in 2003–2004 (nodes B–D in Fig. 1) with particularly
notable expansion of node D in 2004. A recent study suggested
the presence of 4 major WNV clades; the “Southeast Costal
Texas” (node Y in Fig. 1) (Davis et al., 2003), the “Eastern US
isolates” clade (node A in Fig. 1), the “Intermediate sister”
clades, and the “North America 2002–2004” clade (node B in
Fig. 1) (Davis et al., 2005). We did not identify any sequencesbelonging to the Southeast Costal Texas node Y clade in blood
donors in 2003–2004. As others have suggested, this variant
may now be extinct (Davis et al., 2005).
The Eastern US clade (node A) was largely comprised of
pre-2002 sequences and has significantly decreased in fre-
quency since 2002 (Beasley et al., 2003; Davis et al., 2005;
Ebel et al., 2004). This study identified only three 2003
sequences from Florida as belonging to this cluster, suggesting
that this variant may also have become extinct as no Eastern
US clade (node A) virus has been reported in 2004–2005
(Bertolotti et al., in press; Davis et al., 2005; Snapinn et al., in
press). Only one member of the Intermediate sister clades
cluster was identified in 2003 in Central Florida (03-120FL
clustering weakly with NY 2003 Albany DQ164189) (Fig. 2)
(Davis et al., 2005). The rest of our sequences belonged to the
North America 2002–2004 group (node B). The identification of
frequent WNV variants belonging to or directly radiating from
nodes C and D, the growing frequency of node C and D
diagnostic E gene mutations in 2003 and 2004, and the high
bootstrap values for these two clusters using full genome data
led us to define them as significant genetic groups rather than
simply minor variants radiating from node B (i.e. expanding
sub-clusters of the North America 2002–2004 group) (Davis et
al., 2005). Further WNV sampling and analysis in mountain and
pacific states in 2005 and 2006 will be required to determine if
node C and D or further descendents remain dominant.
In 2003 the node C and radiating variants appeared largely
restricted to the Northern half of the central and mountain states
(Alberta, North Dakota, South Dakota, Wyoming, Colorado and
Iowa). In 2004 this lineage also appeared further South in New
Mexico, Arkansas, and again Colorado. The transportation of
WNV by migratory and dispersing resident birds is well
documented and is the most likely source for the spread of
WNV throughout North America. It is interesting to speculate on
a role for migrating birds on the continental central flyway
(http://www.birdnature.com/flyways.html) in bringing node C
variant south in late 2003. The node D and radiating variants
were initially detected in 2003 thinly distributed among node B
variants throughout the central states from Canada to Texas but
became the dominant variants in 2004 among the sampled
viruses in Colorado and Arizona. Spread of this lineage
westward to New Mexico, Arizona, Colorado, and Nevada
may have been facilitated by bird hosts ofWNV that have amore
limited range. The California WNV genetic cluster detectable in
the Los Angeles area in 2004 (and also including San Francisco
and San Diego variants when analyzing full genome sequence
data) descends from the main North America 2002–2004 cluster
(node B) rather than the node D variants seen the same year in
Arizona or Nevada. The 2004 California WNV therefore
appeared to have leaped from the central states while the 2004
mountain states (AZ, CO, NV) viruses were mostly derived from
2003 minority variant(s) from the central states.
Also of interest was the observation that in a subset of cases a
high frequency of WNV variants collected the same year by the
same blood bank contained genetic signatures distinct from all
other sampled WNV. The majority of WNV in the Los Angeles,
CA area, San Antonio, TX, Shreveport, LA, and significant
226 B.L. Herring et al. / Virology 363 (2007) 220–228minority in Grand Junction, CO and Oklahoma City, OK,
carried viral polymorphisms seen in no other regions. Nine out
of ten variants collected in Tempe, AZ were identical in their E
gene all belonging to node D. Geographic concentrations of
closely related variants may be explained by viral founder
effects whereby only one or a few WNV initially colonize a
local area. Descendents of one or a few introduced viruses may
rapidly infect the pool of local birds through insect vectors
thereby amplifying any genetic polymorphisms initially carried
by the founding virus. The majority of human infections in the
same locality (i.e. collected by the same blood bank) would
therefore be derived from one or a very few local WNV
colonization events. The complexity of an arbovirus expansion
into geographically diverse and complex environments, fol-
lowed in some areas by yearly re-emergences, is doubtlessly
subject to many influences. We propose that the high level of
viral genetic homogeneity seen during some outbreaks reflects
the stochastic introduction of one or a very few infected vectors
into a susceptible area followed by rapid local amplification.
The highly focalized distribution of WNVoutbreaks, as seen by
a zip code study of WNV prevalence in blood donors in central
plains states, is consistent with such stochastic WNV introduc-
tions precipitating local outbreaks (Kleinman et al., 2005). A
recent study using available Genbank sequence from North
America plus 68 animal WNV E sequences from different
counties in Illinois showed low but significant structure in their
geographic distribution together with temporally increasing
genetic diversity and divergence from their last common
ancestor (Bertolotti et al., in press). Our results confirm the
growing genetic distance of North American WNV from their
presumably ancestral NY99 sequence and, at least in some
locations, a detectable degree of geographic clustering of related
variants (Beasley et al., 2003; Davis et al., 2003, 2004, 2005).
WNV in human hosts was also sampled in two blood centers
in consecutive years. In Albuquerque, NM the three 2003 strains
sampled belonged to node B (and radiating variants) while all
eight tested in 2004 belonged to node C or D (and radiating
variants) suggesting a re-introduction of WNV rather than over
wintering and re-emergence of the local 2003 variants. Twelve
WNV variants were sampled from Rapid City, SD in 2003 and
two in 2004. Both time points showing the presence of node B
and D variants so that viral diversity remained high in this region
of repeated WNV epidemics due to either multiple re-introduc-
tions and/or over-wintering of 2003 variants.
WNV variants from 2003 and 2004 therefore confirmed the
ongoing expansion of the North American 2002–2004 clade
into viremic blood donors (Davis et al., 2005) (node B) and also
identified expanding variants (nodes C and D), all sharing the
V159A mutation in the E gene relative to their progenitor in
node A. WNV containing the E-V159A mutations have been
reported as early as 2001 in Alabama and in 2002 in Texas,
Georgia, Illinois, Colorado, and Western Canada (Davis et al.,
2005). In NY state this mutation was found in 55% of 2002 and
85% of 2003 strains (Beasley et al., 2003; Davis et al., 2005;
Ebel et al., 2004). Viruses carrying the V159A mutation display
higher transmission efficiency in Culex spp (Ebel et al., 2004),
possibly accounting for these successful expansion of thesevariants whose initial explosive growth is also reflected in the
rapid generation of novel E-V159A derived variants (Snapinn et
al., in press). It is interesting to speculate whether the amino
acid mutations associated with node D expansion, the 2004
Californian cluster or the Grand Junction, CO cluster represent
neutral polymorphisms or selected mutations conferring selec-
tive advantages to these successful WNV variants. Replicative
fitness advantages might be of a general nature or restricted to
the regional conditions encountered where these variants became
dominant (e.g. replication in local species of birds and insect
vectors). Surprisingly the same synonymous E gene mutation
(C1974U) found in node D was also detected in a different
genetic background leading to node X found in 2000 in New
York state indicating that this mutation arose and was amplified
twice. Whether other mutations characterizing expanding node
C and D variants reflect ongoing selection and adaptation or
simple genetic drift will require detailed phenotypic compar-
isons of these expanding WNV variants (Ebel et al., 2004).
Materials and methods
Human samples
Infected human plasma samples were obtained as part of
normal blood donor screening for WNV RNA at blood centers
across the USA and Canada (Busch et al., 2005; Kleinman et al.,
2005). Samples were obtained from 46 blood centers in 25
states and from three Canadian provinces during the epidemic
seasons of 2003 and 2004 (Table 1). A total of 179 samples
were sequenced. All studies were approved by the UCSF CHR.
E gene RT-nPCR and sequencing
Total viral RNAwas extracted from plasma aliquots using the
QIAamp viral RNA minikit (Qiagen, Valencia, CA) as per the
manufacturer's instructions and collected in 50 μl of elution
buffer containing 40 U of Protector RNAse inhibitor (Roche
Diagnostic Corporation, Indianapolis, IN). First strand cDNA
synthesis was initiated using 10 μl of RNA, 200 ng random
oligonucleotide hexamers, and 200 U of Superscript II RNAse
H− reverse transcriptase (Invitrogen, Carlsbad, CA) in a final
volume of 20 μl. A 1564 bp fragment of the E gene was then
amplified by nested PCR. First round PCR reactions (50 μl)
contained 5 μl cDNA and 10 pmol each of sense WNV-E-F1
CTGGTGGCAGCCGTCATTGGTTGGATGCTTGGG and
antisenseWNV-E-R1ACACTCCACTTCCACATCTCAGCTC-
TTGCCG primers (first round with 1.25 U of Taq DNA
polymerase (Promega, Madison, WI), 1.5 mmol/L MgCl2, and
200 mmol/L dNTPs). Second round reactions were initiated with
2 μl from first round reaction and included 10 pmol each of sense
WNV-E-F2 CCATGCAGAGAGTTGTGTTTGTCGTGC and
antisense WNV-E-R2 GCCGGCTGATGTCTATGGCACACCC
primers. PCR cycling conditions for the amplification of WNV E
gene were denaturation at 94 °C for 30 s, annealing at 54 °C for
first PCR round and 56 °C for second round for 30 s, extension at
72 °C for 70 s for 35 cycles. Amplified products were directly
sequenced following purification using the QIAquick PCR
227B.L. Herring et al. / Virology 363 (2007) 220–228Purification Kit (Qiagen). Sequencing was preformed using both
second round forward and reverse primers and an additional
internal primer (S1 CTCCACACAGGTTGGAGCCACT-
CAGGCAGG) and the BigDye Version 3.0 Dye Terminator
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) on
an ABI 3700 automated capillary sequencer.
Full genome RT-nPCR and sequencing
WNV full genome was amplified and sequenced in four
fragments. Viral RNA was extracted as described above using
280 μl of plasma. First strand cDNA synthesis was initiated using
14 μl of RNA and 0.5 μg of either primer R1, R2, R3, or R4a
(Table 2) and 400 U of murine leukemia virus reverse
transcriptase (Promega) in a final volume of 25 μl. For
amplification of each portion of the genome, a nested PCR was
performed using 5 μl of each cDNA and TaKaRa Ex Taq DNA
polymerase (TaKaRa Shuzo Co., LTD, Shiga, Japan). The first
round primers used for each of the four genomic fragments were
F1 and R1, F2 and R2, F3 and R3, and F4a and R4a. The second
round primers were respectively nF1 and nR1, nF2 and nR2, nF3
and nR3, and nF4a and nR4a (Table 2). The PCR cycles were run
as follows: 3 min at 94 °C, followed by 10 cycles of 15 s at 94 °C,
30 s at 54 °C (fragment 4) or 55 °C (fragment 1) or 56 °C
(fragments 2 and 3), 3 min at 68 °C, and 20 cycles of 15 s at
94 °C, 30 s at 54 °C, 55 °C or 56 °C, 3 min plus 10 extra seconds
added at each new cycle at 68 °C. A single band of 2.8–3.2 kb,
depending on the amplicon, was detected on 0.8% agarose gel.
PCR products were purified and sequenced as described above.
Sequencing primers are listed in Table 2. Sequences were edited
manually using EditView and were assembled into a single
contig and then aligned using the Seqman and Megalign
programs, respectively (DNAstar, Inc., Madison, WI).
Network analysis
A median joining network was constructed using NET-
WORK version 4.200 free software obtained from http://www.
fluxus-engineering.com (Bandelt et al., 1999). Program default
settings were used.
Phylogenetic analysis
Nearly complete E gene sequences from genomic position
1055–2413 (E gene ORF is 967–2469) and nearly full WNV
ORF from genomic position 108–10616 (WNV ORF is 97–
10395) were aligned using ClustalX (Thompson et al., 1997).
Phylogenetic analysis was performed using PAUP* 4.0
(Swofford, 2002). Maximum Likelihood (ML) phylogenetic
trees were constructed using a heuristic search employing the
general time reversible model of substitution as determined by
hierarchical likelihood ratio test scores criteria in Modeltest 3.06
(Posada and Crandall, 1998). A starting tree was obtained by
stepwise addition and branch swapping was performed using
sub-pruning regrafting. Base frequency, gamma distribution,
and transition transversion ratios were determined by Modeltest
3.06. Bootstrap analysis (100 replicates) was performed on eachML tree. Pair-wise genetic distances were calculated using nu-
cleotide sequences and ML settings identical to those used for
phylogenetic analysis.
WNV sequences generated from this study have been
submitted to GenBank under accession numbers DQ431693-
DQ431712 for full genomes and DQ911843-DQ912021 for E
region.
Acknowledgments
We acknowledge support from the Blood Systems Founda-
tion, participating blood centers, as well as the CDC/NCID
(R01-CI-000214).
References
Bandelt, H.J., Forster, P., Rohl, A., 1999. Median-joining networks for inferring
intraspecific phylogenies. Mol. Biol. Evol. 16 (1), 37–48.
Beasley, D.W., Davis, C.T., Guzman, H., Vanlandingham, D.L., Travassos da
Rosa, A.P., Parsons, R.E., Higgs, S., Tesh, R.B., Barrett, A.D., 2003.
Limited evolution of West Nile virus has occurred during its southwesterly
spread in the United States. Virology 309 (2), 190–195.
Bertolotti, L., Kitron, U., Goldberg, T.L., in press. Diversity and evolution of
West Nile virus in Illinois and The United States, 2002–2005. Virology
(Available online since Nov 20, 2006)
Blitvich, B.J., Fernandez-Salas, I., Contreras-Cordero, J.F., Marlenee, N.L.,
Gonzalez-Rojas, J.I., Komar, N., Gubler, D.J., Calisher, C.H., Beaty, B.J.,
2003. Serologic evidence of West Nile virus infection in horses, Coahuila
State, Mexico. Emerging Infect. Dis. 9 (7), 853–856.
Busch, M.P., Caglioti, S., Robertson, E.F., McAuley, J.D., Tobler, L.H.,
Kamel, H., Linnen, J.M., Shyamala, V., Tomasulo, P., Kleinman, S.H., 2005.
Screening the blood supply for West Nile virus RNA by nucleic acid
amplification testing. N. Engl. J. Med. 353 (5), 460–467.
Busch, M.P., Wright, D.J., Custer, B., Tobler, L.H., Stramer, S.L., Kleinman,
S.H., Prince, H.E., Bianco, C., Foster, G., Petersen, L.R., Nemo, G.,
Glynn, S.A., 2006. West Nile virus infections projected from blood donor
screening data, United States, 2003. Emerg. Infect. Dis. 12 (3), 395–402.
CDC, 2002. West Nile Virus Activity—United States, October 10–16, 2002,
and update on West Nile Virus infections in recipients of blood transfusions.
Morb. Mortal Wkly. Rep. 51 (41), 929–931.
Davis, C.T., Beasley, D.W., Guzman, H., Raj, R., D'Anton, M., Novak, R.J.,
Unnasch, T.R., Tesh, R.B., Barrett, A.D., 2003. Genetic variation among
temporally and geographically distinct West Nile virus isolates, United
States, 2001, 2002. Emerging Infect. Dis. 9 (11), 1423–1429.
Davis, C.T., Beasley, D.W., Guzman, H., Siirin, M., Parsons, R.E., Tesh, R.B.,
Barrett, A.D., 2004. Emergence of attenuated West Nile virus variants in
Texas, 2003. Virology 330 (1), 342–350.
Davis, C.T., Ebel, G.D., Lanciotti, R.S., Brault, A.C., Guzman, H., Siirin, M.,
Lambert, A., Parsons, R.E., Beasley, D.W., Novak, R.J., Elizondo-Quiroga,
D., Green, E.N., Young, D.S., Stark, L.M., Drebot, M.A., Artsob, H., Tesh,
R.B., Kramer, L.D., Barrett, A.D., 2005. Phylogenetic analysis of North
American West Nile virus isolates, 2001–2004: evidence for the emergence
of a dominant genotype. Virology 342 (2), 252–265.
Ebel, G.D., Carricaburu, J., Young, D., Bernard, K.A., Kramer, L.D., 2004.
Genetic and phenotypic variation of West Nile virus in New York, 2000–
2003. Am. J. Trop. Med. Hyg. 71 (4), 493–500.
Estrada-Franco, J.G., Navarro-Lopez, R., Beasley, D.W., Coffey, L., Carrara,
A.S., Travassos da Rosa, A., Clements, T., Wang, E., Ludwig, G.V.,
Cortes, A.C., Ramirez, P.P., Tesh, R.B., Barrett, A.D., Weaver, S.C., 2003.
West Nile virus in Mexico: evidence of widespread circulation since July
2002. Emerging Infect. Dis. 9 (12), 1604–1607.
Harrington, T., Kuehnert, M.J., Kamel, H., Lanciotti, R.S., Hand, S., Currier,
M., Chamberland, M.E., Petersen, L.R., Marfin, A.A., 2003. West Nile
virus infection transmitted by blood transfusion. Transfusion 43 (8),
1018–1022.
228 B.L. Herring et al. / Virology 363 (2007) 220–228Holland, J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S., VandePol, S.,
1982. Rapid evolution of RNA genomes. Science 215 (4540), 1577–1585.
Hollinger, F.B., Kleinman, S., 2003. Transfusion transmission of West Nile
virus: a merging of historical and contemporary perspectives. Transfusion 43
(8), 992–997.
Jerzak, G., Bernard, K.A., Kramer, L.D., Ebel, G.D., 2005. Genetic variation in
West Nile virus from naturally infected mosquitoes and birds suggests
quasispecies structure and strong purifying selection. J. Gen. Virol. 86
(Pt. 8), 2175–2183.
Jia, X.Y., Briese, T., Jordan, I., Rambaut, A., Chi, H.C., Mackenzie, J.S.,
Hall, R.A., Scherret, J., Lipkin, W.I., 1999. Genetic analysis of West Nile
New York 1999 encephalitis virus. Lancet 354 (9194), 1971–1972.
Kleinman, S., Glynn, S.A., Busch, M., Todd, D., Powell, L., Pietrelli, L., Nemo,
G., Schreiber, G., Bianco, C., Katz, L., 2005. The 2003West Nile virus United
States epidemic: theAmerica's Blood Centers experience. Transfusion 45 (4),
469–479.
Komar, O., Robbins, M.B., Contreras, G.G., Benz, B.W., Klenk, K., Blitvich, B.J.,
Marlenee, N.L., Burkhalter, K.L., Beckett, S., Gonzalvez, G., Pena, C.J.,
Peterson, A.T., Komar, N., 2005. West Nile virus survey of birds and mosqui-
toes in the Dominican Republic. Vector Borne Zoonotic Dis. 5 (2), 120–126.
Lanciotti, R.S., Roehrig, J.T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise,
B., Volpe, K.E., Crabtree, M.B., Scherret, J.H., Hall, R.A., MacKenzie, J.S.,
Cropp, C.B., Panigrahy, B., Ostlund, E., Schmitt, B., Malkinson, M., Banet,
C., Weissman, J., Komar, N., Savage, H.M., Stone, W., McNamara, T.,
Gubler, D.J., 1999. Origin of the West Nile virus responsible for an outbreak
of encephalitis in the northeastern United States. Science 286 (5448),
2333–2337.
Lanciotti, R.S., Ebel, G.D., Deubel, V., Kerst, A.J., Murri, S., Meyer, R., Bowen,
M., McKinney, N., Morrill, W.E., Crabtree, M.B., Kramer, L.D., Roehrig,
J.T., 2002. Complete genome sequences and phylogenetic analysis of
West Nile virus strains isolated from the United States, Europe, and the
Middle East. Virology 298 (1), 96–105.
Lefrancois, T., Blitvich, B.J., Pradel, J., Molia, S., Vachiery, N., Pallavicini, G.,Marlenee, N.L., Zientara, S., Petitclerc, M., Martinez, D., 2005. West Nile
virus surveillance, Guadeloupe, 2003–2004. Emerging Infect. Dis. 11 (7),
1100–1103.
Montgomery, S.P., Brown, J.A., Kuehnert, M., Smith, T.L., Crall, N., Lanciotti,
R.S., Macedo de Oliveira, A., Boo, T., Marfin, A.A., 2006. Transfusion-
associated transmission of West Nile virus, United States 2003 through
2005. Transfusion 46 (12), 2038–2046.
Murgue, B., Zeller, H., Deubel, V., 2002. The ecology and epidemiology ofWest
Nile virus in Africa, Europe and Asia. Curr. Top. Microbiol. Immunol. 267,
195–221.
Nash, D., Mostashari, F., Fine, A., Miller, J., O'Leary, D., Murray, K., Huang,
A., Rosenberg, A., Greenberg, A., Sherman, M., Wong, S., Layton, M.,
2001. The outbreak of West Nile virus infection in the New York City area in
1999. N. Engl. J. Med. 344 (24), 1807–1814.
Pealer, L.N., Marfin, A.A., Petersen, L.R., Lanciotti, R.S., Page, P.L., Stramer,
S.L., Stobierski, M.G., Signs, K., Newman, B., Kapoor, H., Goodman, J.L.,
Chamberland, M.E., 2003. Transmission of West Nile virus through blood
transfusion in the United States in 2002. N. Engl. J. Med. 349 (13),
1236–1245.
Posada, D., Crandall, K.A., 1998. MODELTEST: testing the model of DNA
substitution. Bioinformatics 14 (9), 817–818.
Swofford, D.L., 2002. PAUP: Phylogenetic Analysis Using Parsimony (and
Other Methods) 4.0 Beta. Florida State University.
Snapinn, K.W., Holmes, E.C., Young, D.S., Bernard, K.A., Kramer, L.D., Ebel,
G.D., in press. Declining Growth Rate of West Nile Virus in North America.
J. Virol. (2006 Dec 20; Epub ahead of print).
Stramer, S.L., Fang, C.T., Foster, G.A., Wagner, A.G., Brodsky, J.P., Dodd,
R.Y., 2005. West Nile virus among blood donors in the United States,
2003 and 2004. N. Engl. J. Med. 353 (5), 451–459.
Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F., Higgins, D.G.,
1997. The CLUSTAL_X windows interface: flexible strategies for multiple
sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25
(24), 4876–4882.
